MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01798nam a2200277 a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
vtls000083461 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
KUKTEM |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20251125100356.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
141114t2011 xxka f 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781849731256 (hbk.) |
| 039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE] |
|---|
| Level of rules in bibliographic description |
201507101241 |
| Level of effort used to assign nonsubject heading access points |
aida |
| Level of effort used to assign subject headings |
201507101240 |
| Level of effort used to assign classification |
aida |
| Level of effort used to assign subject headings |
201503191219 |
| Level of effort used to assign classification |
nadia |
| -- |
201411140954 |
| -- |
ezzatul |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
UMP |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
|---|
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
RM301.25 .N49 2011 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
New frontiers in chemical biology : |
| Remainder of title |
enabling drug discovery / |
| Statement of responsibility, etc. |
edited by Mark E. Bunnage |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Cambridge, UK : |
| Name of publisher, distributor, etc. |
RSC Pub., |
| Date of publication, distribution, etc. |
c2011 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xi, 316 p. : |
| Other physical details |
ill. |
| Dimensions |
24 cm. |
| 490 0# - SERIES STATEMENT |
|---|
| Series statement |
RSC drug discovery series ; |
| Volume/sequential designation |
no.5 |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Includes bibliographical references and index |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
The chemical genetic approach : the interrogation of biological mechanisms with small molecule probes / Martin Fisher and Adam Nelson -- Applications for activity-based probes in drug discovery / L.E. Edgington and M. Bogyo -- Targeted intracellular protein degradation as a potential therapeutic strategy / A.R. Schneekloth and C.M. Crews -- Chemical biology of stem cell modulation / Stephen G. Davies and Angela J. Russell -- Chemical biology of histone modifications / Nathan R. Rose, Christopher J. Schofield and Tom D. Heightman -- Chemologics / Lyn H. Jones -- Antibody-drug conjugates in oncology / Philip R. Hamann and Russell G. Dushin -- Drug discovery by DNA-encoded libraries / Yizhou Li, Zheng Zhu and Xiaoyu Li |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug development |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Biochemistry |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Bunnage, Mark E. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Royal Society of Chemistry (Great Britain) |
| 856 41 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Table of contents only |
| Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/enhancements/fy1213/2011288337-t.html">http://www.loc.gov/catdir/enhancements/fy1213/2011288337-t.html</a> |